Sanyou Bio conducted a full review of its Intelligent Super-trillion Molecule Discovery Platform. As the core technology of the platform, the intelligent super-trillion molecule library boasts a ...

In this part of his Pharmaceutical Executive video interview, Ian Chan, CEO of Abpro discusses the advantages of their ...

Discover how next-generation kinase inhibitors are transforming clinical therapy byovercoming resistance and enhancing ...

Moreover, the number of players is likely to be significantly less than in the small molecule AI space, considering the complexity of building AI models for intricate molecules like antibodies.

Harbour BioMed (HKEX: 02142, the "Company"), a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and ...

Antibody-DNA conjugates were used to recognize the epithelial cell adhesion molecule (EpCAM) antigen on the TAE surface and quantify the antigen using qPCR for cancer analysis. Discussion: This method ...

By optimizing immunization strategies and screening workflows, the affinity and specificity of antibodies within the library have been improved, significantly increasing its application value in drug ...

FIGURE 3. Basic structure of antibody. Each IgG antibody molecule consists of four polypeptide chains (two identical light chains and two identical heavy chains joined by disulfide bonds) and has two ...

and molecular profile information of disease-relevant targets – as well as the criteria that make for a successful antibody molecule, like affinity, specificity, and developability – to come ...

Two of Bambusa’s bispecific antibody candidates for immunological and inflammatory disorders are set to enter the clinic in ...

Eleven CRDMOs collaborate to form IPSO with the aim to elevate India’s position in the global pharmaceutical ...

Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel ...